<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Noncontrast MRA of Pedal Arteries in Type II Diabetes" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/noncontrast-mra-of-pedal-arteries-in-type-ii-diabetes/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/noncontrast-mra-of-pedal-arteries-in-type-ii-diabetes/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2015-03-31T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Noncontrast MRA of Pedal Arteries in Type II Diabetes" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-10T02:43:55+00:00","datePublished":"2015-03-31T17:00:00+00:00","description":"Rationale and Objectives","headline":"Noncontrast MRA of Pedal Arteries in Type II Diabetes","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/noncontrast-mra-of-pedal-arteries-in-type-ii-diabetes/"},"url":"https://clinicaltree.github.io/posts/noncontrast-mra-of-pedal-arteries-in-type-ii-diabetes/"}</script><title>Noncontrast MRA of Pedal Arteries in Type II Diabetes | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Noncontrast MRA of Pedal Arteries in Type II Diabetes</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Noncontrast MRA of Pedal Arteries in Type II Diabetes</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1427821200" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Mar 31, 2015 </em> </span> <span> Updated <em class="" data-ts="1681094635" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 10, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Lijuan Zhang MD</a> </em>, <em> <a href="">Xin Liu MD</a> </em>, <em> <a href="">Zhaoyang Fan PhD</a> </em>, <em> <a href="">Na Zhang MS</a> </em>, <em> <a href="">Yiu-Cho Chung PhD</a> </em>, <em> <a href="">Weiqi Liao MMed</a> </em>, <em> <a href="">Hairong Zheng PhD</a> </em>, <em> <a href="">Debiao Li PhD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="1909 words"> <em>10 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Noncontrast magnetic resonance angiography (NC-MRA) of pedal artery remains challenging because of the global and regional disease load, tissue integrity, and altered microcirculation. This study aims to investigate the feasibility of the NC-MRA of pedal arteries with flow-sensitive dephasing–prepared steady-state free precession (FSD-SSFP) and to explore the effect of disease load of type II diabetes on the vessel depiction.</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>FSD-SSFP was performed on a 1.5-T magnetic resonance system before the contrast-enhanced MRA (CE-MRA) as a reference standard in 39 consecutive diabetic subjects (29 men and 16 women, aged 57.9 ± 11.4 years). Two experienced radiologists evaluated the overall artery visibility (VA) and the contamination from soft tissue (SC) and veins (VC) with a four-point scale. Chronic complications and measures including random blood glucose (RBG), lipid panel, body mass index, risk of diabetic foot ulcers (RDF), and glycated hemoglobin (HbA1c) by the imaging were recorded as disease load indicators. Spearman rank correlation and ordinal regression were performed to investigate the effect of disease load on the depiction of pedal arteries.</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>The measurement of RBG and RDF were significantly correlated with the VC in CE-MRA and with the overall visibility of pedal arteries in NC-MRA ( <em>P</em> &lt; .025 and <em>P</em> &lt; .001, respectively). Blood pressure was the only parameter that was significantly associated with SC in NC-MRA with FSD-SSFP ( <em>P</em> &lt; .025). For CE-MRA the effect of RDF on the overall VA manifested a significant linear trend ( <em>P</em> &lt; .001), and the level of RBG was substantially associated with the VC ( <em>P</em> &lt; .025) without significantly impacting VA and SC. Hypertension only correlated with SC in NC-MRA. VA was found independent of the presence of diabetic nephropathy, coronary artery disease, abnormal lipid panel, HbA1c (75.0%), or optimized m 1 value that ranged from 70 to 160 mT⋅ms 2 /m (mean, 125 ± 18 mT⋅ms 2 /m) in this study.</p><h2 id="conclusions"><span class="mr-2">Conclusions</span><a href="#conclusions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>FSD-SSFP proved to be a useful modality of NC-MRA for pedal artery imaging in diabetic patients. The vessel depiction is subject to the local and systemic disease load of type II diabetes. Technical optimization of the flow-sensitive dephasing gradient moment and properly choosing candidate would help augment the potential of this technique in patient care of peripheral artery disease.</p><p>Peripheral artery disease (PAD) is a typical macrovascular complication that typically affects arteries below the knee in type II diabetes . The awareness and detection of PAD may be limited as a substantial proportion of patients are asymptomatic or have atypical manifestations , although significant impairment of blood flow may have already occurred . Effective screening would be useful to facilitate the early identification of PAD, thus improving prognosis and lowering the cost of the disease .</p><p>Morphological and functional parameters of peripheral arteries derived from noninvasive assessments are well accepted in clinical practice. Ankle–brachial index (ABI) is commonly used as a convenient tool in PAD screening with high sensitivity and specificity, especially for populations aged greater than 50 years with significant hemodynamic abnormalities . However, the range and severity of the diseased arteries may not be readily indicated by this index, and the reliability of ABI can be compromised by the presence of arterial calcification. Pulse wave velocity, computed tomography angiography (CTA), magnetic resonance angiography (MRA), and digital subtraction angiography (DSA) are valuable imaging modalities that provide morphological and functional details of the diseased arteries for the purposes of determining revascularization and grafting or stent patency. However, a substantial population of diabetic patients is excluded from CTA or contrast-enhanced MRA (CE-MRA) in clinical practice concerning the high dose of ionizing radiation and/or contrast agent–induced nephropathy . Therefore, the development of MRA techniques that requires no contrast medium becomes a need of significant importance for the purpose of peripheral artery imaging in diabetes.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="methods"><span class="mr-2">Methods</span><a href="#methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/NoncontrastMRAofPedalArteriesinTypeIIDiabetes/0_1s20S1076633214004565.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/NoncontrastMRAofPedalArteriesinTypeIIDiabetes/0_1s20S1076633214004565.jpg" alt="Figure 1, Illustration of normal pedal artery anatomy. (a) Anterior view. (1) Distal anterior tibial artery, (2) dorsal artery of foot, (3) lateral tarsal arteries, (4) arcuate artery, (5) deep perforating artery, (6) dorsal metatarsal artery for hallux. (b) Lateral view. (1) Distal anterior tibial artery, (2) dorsal artery of foot, (3) lateral tarsal artery, (5) deep perforating artery, (8) lateral and (9) medial plantar arteries, (10) pedal arch, (11) distal posterior tibial artery [Courtesy of Chomel et al. (16) ]. Visibility of arteries numbered 2, 3, 4, 8, 9, and 10 was assessed in this study." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 1</p><p>Summary of the Distribution of Abnormal Clinical Laboratory Tests, Measures, and Complications of the 39 Subjects</p><p>Measure Lipid Panel RBG HbA1c BMI LDL Triglycerides HDL TC Abnormality rate (%) 90.9 88.9 62.5 60 86.7 71.8 43.5 Complication DR Atherosclerosis Dneuro Dnephro Hypertension FW CAD % 100 84.6 69.2 56.4 53.8 30.8 23.1</p><p>BMI, body mass index; CAD, coronary artery disease; Dnephro, diabetic nephropathy; Dneuro, diabetic neuropathy; DR, diabetic retinopathy; FW, diabetic foot wound; HbA1c, glycated hemoglobin; HDL, high-density lipoprotein; LDL, low-density lipoprotein; RBG, random blood glucose; TC, total cholesterol.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/NoncontrastMRAofPedalArteriesinTypeIIDiabetes/1_1s20S1076633214004565.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/NoncontrastMRAofPedalArteriesinTypeIIDiabetes/1_1s20S1076633214004565.jpg" alt="Figure 2, Representative images of pedal artery imaging with flow-sensitive dephasing–prepared steady-state free precession (FSD-SSFP) and contrast-enhanced magnetic resonance angiography (CE-MRA) of a diabetic subject (M, 45 years old, m 1 = 140 mT⋅ms 2m). (a) Diastolic phase of FSD-SSFP; (b) systolic phase of FSD-SSFP; (c) subtraction of images obtained in diastole and systole cycles; (d) maximum-intensity projection (MIP) image of FSD-SSFP; (e) frontal ( upper ) and lateral ( lower ) views of the MIP images of CE-MRA with the application of gadolinium-DTPA." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/NoncontrastMRAofPedalArteriesinTypeIIDiabetes/2_1s20S1076633214004565.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/NoncontrastMRAofPedalArteriesinTypeIIDiabetes/2_1s20S1076633214004565.jpg" alt="Figure 3, Significant contamination from soft tissue and pedal veins was seen in a subject with diabetic foot (a) . The overall visibility of arteries was impaired without significant soft tissue or vein contamination for both flow-sensitive dephasing–prepared steady-state free precession (FSD-SSFP) (b) and contrast-enhanced magnetic resonance angiography (CE-MRA) (c) in another subject with abnormal random blood glucose." class="lazyload" data-proofer-ignore></a></p><p>Table 2</p><p>Summary of the Scoring of the Overall VA, SC, and VC Based on the MIP FSD-SSFP Images of 234 Main Proximal Pedal Runoffs</p><p>Image Quality Scoring (Mean ± Standard Deviation) SC VC VA CE-MRA 2.4 ± 0.7 2.0 ± 0.7 2.3 ± 0.8 FSD-SSFP MRA 2.0 ± 1.2 1.4 ± 0.5 2.6 ± 0.9</p><p>CE, contrast enhanced; FSD-SSFP, flow-sensitive dephasing–prepared steady-state free precession; MIP, maximum-intensity projection; MRA, magnetic resonance angiography; SC, soft tissue contamination; VA, visibility of arteries; VC, venous contamination.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 3</p><p>Correlation Coefficient Between Disease Indicators and Image Quality for Both NC-MRA with FSD-SSFP and CE-MRA</p><p>Image Quality Indicator MRA RBG RDF Dnephro Blood Pressure HbA1c CAD m 1 VA NC 0.42* 0.39* — — — — — CE — — — — — — — VC NC — — — — — — — CE 0.44* 0.62** △△ — — — — — SC NC — 0.38* △ — 0.42* — — — CE — — — — — — —</p><p>CAD, coronary artery disease; CE, contrast enhanced; Dnephro, diabetic nephropathy; FSD-SSFP, flow-sensitive dephasing–prepared steady-state free precession; HbA1c, glycated hemoglobin; m 1 , first-order gradient moment; MRA, magnetic resonance angiography; NC, noncontrast; RBG, random blood glucose; RDF, risk of diabetic foot ulcer; SC, soft tissue contamination; VA, visibility of pedal artery; VC, vein contamination.</p><p>Bonferroni approach was applied to control the type I error.</p><p>∗ Spearman rho correlation and △ Cochran–Armitage trend test. * ,△ <em>P</em> &lt; .025; ∗∗,△△ <em>P</em> &lt; .001; — <em>P</em> &gt; .05.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="conclusions-1"><span class="mr-2">Conclusions</span><a href="#conclusions-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Selvin E., Erlinger T.P.: Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999–2000. Circulation 2004; 110: pp. 738-743.</p><li><p>2. Criqui M.H., Veronica V., Denenberg J.O., et. al.: Ethnicity and peripheral arterial disease: the San Diego Population Study. Circulation 2005; 112: pp. 2703-2707.</p><li><p>3. Orchard T.J., Strandness D.E.: Assessment of peripheral vascular disease in diabetes. Report and recommendations of an international workshop sponsored by the American Diabetes Association and the American Heart Association September 18–20, 1992 New Orleans, Louisiana. Circulation 1993; 88: pp. 819-828.</p><li><p>4. Jude E.B., Oyibo S.O., Chalmers N., et. al.: Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetic Care 2001; 24: pp. 1433-1437.</p><li><p>5. Meijer W.T., Hoes A.W., Rutgers D., et. al.: Peripheral arterial disease in the elderly: the Rotterdam Study. Arteriosclerosis, Thrombosis, and Vascular Biology 1998; 18: pp. 185-192.</p><li><p>6. Fowkes F.G.R., Housley E., Cawood E.H.H., et. al.: Edinburgh artery study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991; 20: pp. 384-392.</p><li><p>7. Belch W., Topol E.S., Agnelli G.M.: Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med 2003; 163: pp. 884-892.</p><li><p>8. Otah K.E., Madan A., Otah E., et. al.: Usefulness of an abnormal ankle-brachial index to predict presence of coronary artery disease in African-Americans. Am J Cardiol 2004; 93: pp. 481-483.</p><li><p>9. Calvin A.D., Misra S., Pflueger A.: Contrast-induced acute kidney injury and diabetic nephropathy. Nat Rev Nephrol 2010; 6: pp. 679-688.</p><li><p>10. Sadowski E.A., Bennett L.K., Chan M.R., et. al.: Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 2007; 243: pp. 148-157.</p><li><p>11. Miyazaki M., Lee V.S.: Nonenhanced MR angiography. Radiology 2008; 248: pp. 20-43.</p><li><p>12. Fan Z., Sheehan J., Bi X., et. al.: 3D noncontrast MR angiography of the distal lower extremities using flow-sensitive dephasing (FSD)-prepared balanced SSFP. Magn Reson Med 2009; 62: pp. 1523-1532.</p><li><p>13. Nakamura K., Miyazaki M., Kuroki K., et. al.: Noncontrast-enhanced peripheral MRA: technical optimization of flow spoiled fresh blood imaging for screening peripheral arterial diseases. MRM 2011; 65: pp. 595-602.</p><li><p>14. Boulton A.J.M., Armstrong D.G., Albert S.F., et. al.: Comprehensive foot examination and risk assessment. Diabetes Care 2008; 31: pp. 1679-1685.</p><li><p>15. Fan Z., Zhou X., Bi X., et. al.: Determination of the optimal first-order gradient moment for flow-sensitive dephasing magnetization-prepared 3D noncontrast MR angiography. Magn Reson Med 2011; 65: pp. 964-972.</p><li><p>16. Chomel S., Douek P., Moulin P., et. al.: Contrast-enhanced MR angiography of the foot: anatomy and clinical application in patients with diabetes. AJR 2004; 182: pp. 1435-1442.</p><li><p>17. Lim R.P., Hecht E.M., Xu J., et. al.: 3D nongadolinium-enhanced ECG-gated MRA of the distal lower extremities: preliminary clinical experience. J Magn Reson Imaging 2008; 28: pp. 181-189.</p><li><p>18. Liu X., Natasha B., Sheehan J., et. al.: Renal transplant: nonenhanced renal MR angiography with magnetization-prepared steady state free precession. Radiology 2009; 251: pp. 535-542.</p><li><p>19. Edmonds M.E., Roberts V.C., Watkins P.J.: Blood flow in the diabetic neuropathic foot. Diabetologia 1982; 22: pp. 9-15.</p><li><p>20. Uccioli L., Mancini L., Giordano A., et. al.: Lower limb arterio-venous shunts, autonomic neuropathy and diabetic foot. Diabetes Res Clin Pract 1992; 16: pp. 123-130.</p><li><p>21. Payne C.B.: Biomechanics of the foot in diabetes mellitus: some theoretical considerations. J Am Podiatr Med Assoc 1998; 88: pp. 285-289.</p><li><p>22. Zhang H.L., Kent K.C., Bush H.L., et. al.: Soft tissue enhancement on time-resolved peripheral magnetic resonance angiography. JMRI 2004; 19: pp. 590-597.</p><li><p>23. Dinh T., Veves A.: Microcirculation of the diabetic foot. Curr Pharm Des 2005; 11: pp. 2301-2309.</p><li><p>24. Fatma A., Mohammed E.: Prevalence of risk factors for diabetic foot complications. BMC family practice 2007; 8: pp. 59.</p><li><p>25. Le Bihan D., Breton E., Lallemand D., et. al.: MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986; 161: pp. 401-407.</p><li><p>26. Le Bihan D., Breton E., Lallemand D., et. al.: Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988; 168: pp. 497-505.</p><li><p>27. Sun P.C., Chen C.S., Kuo C.D., et. al.: Impaired microvascular flow motion in subclinical diabetic feet with sudomotor dysfunction. Microvasc Res 2012; 83: pp. 243-248.</p><li><p>28. Raskin P., Pietri A., Unger R., et. al.: The effect of diabetic control on skeletal muscle capillary basement membrane width in patients with type 1 diabetes mellitus. New Engl J Med 1983; 309: pp. 1546-1550.</p><li><p>29. Overall W.R., Conolly S.M., Nishimura D.G., et. al.: Oscillating dual-equilibrium steady-state angiography. MRM 2002; 47: pp. 513-522.</p><li><p>30. Weitz J.I., Byrne J., Clagett P., et. al.: Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation 1996; 94: pp. 3026-3049.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-22/'>Volume 22</a>, <a href='/categories/issue-4/'>Issue 4</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Noncontrast%20MRA%20of%20Pedal%20Arteries%20in%20Type%20II%20Diabetes%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fnoncontrast-mra-of-pedal-arteries-in-type-ii-diabetes%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Noncontrast%20MRA%20of%20Pedal%20Arteries%20in%20Type%20II%20Diabetes%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fnoncontrast-mra-of-pedal-arteries-in-type-ii-diabetes%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fnoncontrast-mra-of-pedal-arteries-in-type-ii-diabetes%2F&text=Noncontrast%20MRA%20of%20Pedal%20Arteries%20in%20Type%20II%20Diabetes%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/acute-stroke-imaging/"><div class="card-body"> <em class="small" data-ts="1427821200" data-df="ll" > Mar 31, 2015 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Acute Stroke Imaging</h3><div class="text-muted small"><p> Rationale and Objectives Magnetic resonance (MR) imaging (MRI) provides information that can be used to estimate the symptom onset in patients with wake-up stroke (WUS). Time-resolved MR angiograp...</p></div></div></a></div><div class="card"> <a href="/posts/assessment-of-liver-function-and-liver-fibrosis-with-dynamic-gd-eob-dtpa-enhanced-mri/"><div class="card-body"> <em class="small" data-ts="1427821200" data-df="ll" > Mar 31, 2015 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Assessment of Liver Function and Liver Fibrosis with Dynamic Gd-EOB-DTPA–Enhanced MRI</h3><div class="text-muted small"><p> Rationale and Objectives To evaluate the ability of segmental linear fitting analysis of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid liver perfusion magnetic resonance imaging (MRI...</p></div></div></a></div><div class="card"> <a href="/posts/can-the-signal-to-noise-ratio-of-choline-in-magnetic-resonance-spectroscopy-reflect-the-aggressivene/"><div class="card-body"> <em class="small" data-ts="1427821200" data-df="ll" > Mar 31, 2015 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Can the Signal-to-Noise Ratio of Choline in Magnetic Resonance Spectroscopy Reflect the Aggressiveness of Endometrial Cancer?</h3><div class="text-muted small"><p> Rationale and Objectives To differentiate endometrial cancer (ECa) from benign lesions in endometrial or in submucosa (BLs-ESm), and investigate whether the signal-to-noise ratio (SNR) of choline-...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/intraindividual-comparison-of-two-methods-of-volumetric-breast-composition-assessment/" class="btn btn-outline-primary" prompt="Older"><p>Intraindividual Comparison of Two Methods of Volumetric Breast Composition Assessment</p></a> <a href="/posts/peer-support-of-a-faculty-writers-circle-increases-confidence-and-productivity-in-generating-scho/" class="btn btn-outline-primary" prompt="Newer"><p>Peer Support of a Faculty “Writers' Circle” Increases Confidence and Productivity in Generating Scholarship</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
